Physical activity limitations in children with severe hemophilia A. does emicizumab make a difference?

Author:

Ahmed Sobhi Hassan ,Laila Metwally Sherief ,Mona Hamdy ,Abeer Salamah ,Osama A El-Agamy

Abstract

Objective: To assess the effect of emicizumab on physical activity in children with severe haemophilia A.Method: The prospective cohort study was conducted from October 2021 to April 2022 at the Paediatric Department of Kafrelsheikh University Hospital, Egypt, in collaboration with the Haematology out-patient clinic of the Paediatric Department, Zagazig University, Egypt, and the Paediatric Department of Cairo University Hospital, Egypt, and comprised children aged 4-18 years with severe haemophilia A who received emicizumab prophylaxis. Paediatric Haemophilia Activities List was used to assess physical activity at baseline and after six months of regular emicizumab prophylaxis. Data was analysed using SPSS 26.Results: There were 29 children, all (100%) boys, with mean age 8.7±3.51 years (range 4-15 years. Of them, 17(58.62%) patients were negative for inhibitors. Median Paediatric Haemophilia Activities List sum score was 59.54 (interquartile range: 50.15-62.05) at baseline which moved up to 84 (interquartile range: 79.05-86.35) post-intervention (p<0.001).Conclusion: Emicizumab prophylaxis improved the level of physical activity in children with severe haemophilia A.Keywords: Emicizumab, Haemophilia, Haematology, PedHAL.

Publisher

Pakistan Medical Association

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3